Microlight3D and partners granted €747K to develop 3D printer for dermal regeneration

The funding will support the nAngioDerm project over the next 36 months

Microlight3D, a French company specializing in high-resolution, micro-scale 3D printing technologies, has received a European grant worth €747,000 ($822,000) for the nAngioDerm project in which it is a partner. A consortium of research groups from across Europe will distribute the funding, including ANR (the French National Research Agency), which is underwriting Microlight3D’s work in the project.

The nAngioDerm project will officially launch in September 2019 and is scheduled to run for the next 36 months. Broadly, its goal is to develop a 3D printing process for dermal regeneration. Microlight 3D and four other European research partners will collaborate to develop a novel solution for patients who are suffering from hard-to-heal wounds caused by ulcers or burns.

Over the next three years, Microlight3D and its partners will pioneer a new 3D printing process and associated products using ion-release biomaterials designed to promote angiogenesis for dermal regeneration. To achieve this, the project will rely heavily on the partners’ respective expertise in tissue engineering, bio-active ions and cell-scaffold 3D printing—Microlight3D’s speciality.

“Microlight3D is very proud to be a partner in nAngioDerm, its first European research consortium,” commented Denis Barbier, CEO of Microlight3D. “Collaborating with such high-level academic organizations on such a key health issue is further recognition of the value of our 3D microprinting technology for regenerative medicine applications. This project is a great opportunity in helping to further develop our micro-scale 3D printing systems for use in future health applications.”

The nAngioDerm project is being led by the Institute for Bioengineering in Catalonia (IBEC), which specializes in bio-active ions and bioengineering, and brings on participation from researchers at the University of Ioannina in Greece, the Universitario Vall d’Hebron Hospital in Spain and the University of Grenoble in France.

Microlight3D, the only non-academic partner, will be tasked with developing a 3D printer and process for cell-scaffold applications. The role is critical in the nAngioDerm project and Microlight3D was selected for the job because of its experience and expertise in 3D printing biomaterials with sub-cell resolution.

Down the line, the ability to 3D print biostructures for dermal regeneration could lead to more sophisticated treatment methods for patients suffering from acute wounds caused by ulcers, burns or surgery. The treatment could lead to reduced medical costs and resources for wound care—currently, the annual cost of managing wounds by the NHS is estimated to be upwards of £4.5 billion.

The nAngioDerm project is part of EuroNanoMed3 (2016-2021), an initiative which supports multidisciplinary and translational research and innovation projects focused on regenerative medicine, diagnostics and targeted delivery systems. EuroNanoMed3 is part of the larger European Horizon 2020 program. 

Tess Boissonneault

Tess Boissonneault moved from her home of Montreal, Canada to the Netherlands in 2014 to pursue a master’s degree in Media Studies at the University of Amsterdam. It was during her time in Amsterdam that she became acquainted with 3D printing technology and began writing for a local additive manufacturing news platform. Now based in France, Tess has over two and a half years experience writing, editing and publishing additive manufacturing content with a particular interest in women working within the industry. She is an avid follower of the ever-evolving AM industry.

Leave a Comment

Recent Posts

Anouk Wipprecht presents new 3D printed Proximity Dress for social distancing

The concept of a mechanical, 3D printed smart dress, to safeguard one's proximity and personal…

8 hours ago

Airbus wins ESA contract to construct third European Service Module for NASA’s Orion spacecraft

The European Space Agency (ESA) has signed a contract with Airbus for the construction of…

14 hours ago

CECIMO presents four points to support AM’s growth in the wake of the COVID-19 crisis

CECIMO, the European Association of Machine Tool Industry and Related Manufacturing Technologies, is actively involved…

16 hours ago

EOS’s SVP Markus Glasser: “Distributing AM to exit the COVID-19 crisis”

The COVID-19 crisis is going to cause a massive shock to global manufacturing, pretending it…

16 hours ago

UpNano 3D prints ISO test specimens with sub-micrometer resolution

UpNano GmbH, a Vienna-based company spun out from TU Wien, has made a breakthrough in…

16 hours ago

The era of commercial human space flight begins on May 30th

After canceling the May 27th attempt due to weather concerns, SpaceX is now targeting Wednesday,…

19 hours ago